Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director

MEDIZONE INTERNATIONAL INC (MZEI) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/11/2018 8-K Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits
Docs: "Medizone International Announces Filing of Voluntary Chapter 7 Bankruptcy Proceeding Kalamazoo, Michigan, May 8, 2018. Medizone International, Inc."
04/24/2018 8-K Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o...
Docs: "In re: Medizone International, Inc. (Case 18-50412), Involuntary Bankruptcy Petition in the United States Bankruptcy Court for the District of Nevada",
"Kalamazoo, Michigan, April 20, 2018. Medizone International, Inc."
03/27/2018 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Shareholder Update"
02/05/2018 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended ; B. Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a 8% convertible note of the Company, in the form attached hereto as Exhibit A , in the aggregate principal amount of US$152,500.00 issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the “Note”), convertible into shares of common stock, $0.001 par value per share, of the Company , upon the terms...",
"Securities Purchase Agreement, by and between the Company and SBI Investments LLC, 2014-1",
"Convertible Promissory Note, made by the Company in favor of L2 Capital, LLC",
"Convertible Promissory Note, made by the Company in favor of SBI Investments LLC, 2014-1",
"Common Stock Purchase Warrant, by and between the Company and L2 Capital LLC",
"Common Stock Purchase Warrant, by and between the Company and SBI Investments LLC, 2014-1",
"Equity Purchase Agreement, by and between the Company and the Investors",
"Registration Rights Agreement, by and between the Company and the Investors",
"Trading Agreement, by and between L2 Capital LLC and SBI Investments LLC, 2014-1",
"Medizone Announces Completion of Financing Kalamazoo, Michigan, January 31, 2018. Medizone International, Inc."
02/01/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement between Medizone International, Inc. and Jude P. Dinges",
"Addendum to Employment Agreement between Medizone International and Jude P. Dinges",
"Medizone International Appoints Jude Dinges to Executive Team Kalamazoo, Michigan, January 30, 2018. Medizone International, Inc."
12/05/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Shareholder Update"
11/03/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement between Medizone International, Inc. and Philip A. Theodore",
"Addendum to Employment Agreement between Medizone International and Philip A. Theodore",
"Addendum to Employment Agreement between Medizone International and Stephanie L. Sorensen",
"Medizone International Appoints Philip Theodore to Executive Team",
"Medizone International concludes exclusive Product Supply and License Agreement with Innovasource",
"AsepticSure â , the only disinfection system in the world that routinely achieves a minimum microbial kill of at least a thousand times greater than conventional cleaning methods,"
10/16/2017 8-K Quarterly results
09/19/2017 8-K Quarterly results
08/28/2017 8-K Quarterly results
08/24/2017 8-K Quarterly results
06/22/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Medizone International Registered to Exhibit AsepticSure at the Military Health System’s Vendor Day",
"AsepticSure® Receives Full Approval of International Electrical Safety Standards AsepticSure approval of international safety standards clears path for global commercialization",
"Effective June 21, 2017, Daniel D. Hoyt",
"Investor Update (June 21, 2017)"
06/08/2017 8-K Form 8-K - Current report
05/31/2017 8-K Form 8-K - Current report
05/23/2017 8-K Form 8-K - Current report
04/25/2017 8-K Form 8-K - Current report
04/07/2017 8-K Form 8-K - Current report
04/06/2017 8-K Form 8-K - Current report
03/03/2017 8-K Form 8-K - Current report
03/01/2017 8-K Form 8-K - Current report
02/28/2017 8-K Form 8-K - Current report
02/27/2017 8-K/A Form 8-K/A - Current report [Amend]
01/25/2017 8-K Form 8-K - Current report
12/19/2016 8-K Form 8-K - Current report
10/26/2016 8-K Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
Docs: "Amended and Restated Distribution Agreement dated effective October 21, 2016",
"Form of New Warrants",
"Medizone International, Manufacturer of AsepticSure, Closes Additional Investment"
10/07/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "RECITALS"
09/30/2016 8-K Other Events
08/19/2016 8-K Other Events
07/12/2016 8-K Form 8-K - Current report
05/06/2016 8-K Form 8-K - Current report
11/17/2015 8-K Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Distribution Agreement dated effective November 12, 2015",
"Form of Subscription Agreement entered into with GYD, S.A. and other investors closing on November 13, 2015",
"Introduced to South America AsepticSureâ, the only hospital disinfection system in the world that achieves 100% bactericidal kill, dramatically reducing new rates of hospital acquired infections in the rooms treated, will be distributed in South America by GYD S.A. Santiago, Chile and San Francisco, California, November 17, 2015. Medizone International, Inc. or Medizone, manufacturer of the AsepticSure® Hospital Disinfection System, and GYD S.A. today announced that they have entered into an agreement for the introduction and distribution of AsepticSure® in South America . Medizone granted GYD S.A exclusive distribution rights for the AsepticSure® system in Chile, Brazil, Colombia and Peru. GYD S.A. will lead the regulatory approval process throughout South America and exclusive distr..."
09/09/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "AsepticSure Proposed for Saudi Arabia to help eliminate MERS-coronavirus"
12/17/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Chairman’s Letter to Shareholders"
10/09/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AsepticSure Developer Medizone International Welcomes Vincent C. Caponi to the Board of Directors"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy